Cite
Goyal L, Sirard C, Schrag M, et al. Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer. Clin Cancer Res. 2020;26(23):6158-6167doi: 10.1158/1078-0432.CCR-20-1310.
Goyal, L., Sirard, C., Schrag, M., Kagey, M. H., Eads, J. R., Stein, S., El-Khoueiry, A. B., Manji, G. A., Abrams, T. A., Khorana, A. A., Miksad, R., Mahalingam, D., Zhu, A. X., & Duda, D. G. (2020). Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(23), 6158-6167. https://doi.org/10.1158/1078-0432.CCR-20-1310
Goyal, Lipika, et al. "Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,23 (2020): 6158-6167. doi: https://doi.org/10.1158/1078-0432.CCR-20-1310
Goyal L, Sirard C, Schrag M, Kagey MH, Eads JR, Stein S, El-Khoueiry AB, Manji GA, Abrams TA, Khorana AA, Miksad R, Mahalingam D, Zhu AX, Duda DG. Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer. Clin Cancer Res. 2020 Dec 01;26(23):6158-6167. doi: 10.1158/1078-0432.CCR-20-1310. Epub 2020 Sep 02. PMID: 32878766.
Copy
Download .nbib